Atlas Trials

Dolutegravir Pediatric Liquid Formulation Study

Clinical trial NCT03921723 · COMPLETED

Trial details

NCT number
NCT03921723
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
2019-05-07
Primary completion
2019-07-25
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.